192 related articles for article (PubMed ID: 34593304)
1. FGF/FGFR signaling: From lung development to respiratory diseases.
Yang L; Zhou F; Zheng D; Wang D; Li X; Zhao C; Huang X
Cytokine Growth Factor Rev; 2021 Dec; 62():94-104. PubMed ID: 34593304
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of fibroblast growth factors and receptor FGFR-1 during vascular remodeling in chronic obstructive pulmonary disease.
Kranenburg AR; De Boer WI; Van Krieken JH; Mooi WJ; Walters JE; Saxena PR; Sterk PJ; Sharma HS
Am J Respir Cell Mol Biol; 2002 Nov; 27(5):517-25. PubMed ID: 12397010
[TBL] [Abstract][Full Text] [Related]
3. Targeting Drugs Against Fibroblast Growth Factor(s)-Induced Cell Signaling.
Agrawal S; Maity S; AlRaawi Z; Al-Ameer M; Kumar TKS
Curr Drug Targets; 2021; 22(2):214-240. PubMed ID: 33045958
[TBL] [Abstract][Full Text] [Related]
4. The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.
Ronca R; Giacomini A; Rusnati M; Presta M
Expert Opin Ther Targets; 2015; 19(10):1361-77. PubMed ID: 26125971
[TBL] [Abstract][Full Text] [Related]
5. FGF/FGFR signaling in adrenocortical development and tumorigenesis: novel potential therapeutic targets in adrenocortical carcinoma.
Tamburello M; Altieri B; Sbiera I; Sigala S; Berruti A; Fassnacht M; Sbiera S
Endocrine; 2022 Sep; 77(3):411-418. PubMed ID: 35583844
[TBL] [Abstract][Full Text] [Related]
6. Chronic obstructive pulmonary disease is associated with enhanced bronchial expression of FGF-1, FGF-2, and FGFR-1.
Kranenburg AR; Willems-Widyastuti A; Mooi WJ; Saxena PR; Sterk PJ; de Boer WI; Sharma HS
J Pathol; 2005 May; 206(1):28-38. PubMed ID: 15772985
[TBL] [Abstract][Full Text] [Related]
7. Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications.
Dianat-Moghadam H; Teimoori-Toolabi L
Curr Drug Targets; 2019; 20(8):852-870. PubMed ID: 30648505
[TBL] [Abstract][Full Text] [Related]
8. The role of fibroblast growth factors in tumor growth.
Korc M; Friesel RE
Curr Cancer Drug Targets; 2009 Aug; 9(5):639-51. PubMed ID: 19508171
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor signaling and inhibition in non-small cell lung cancer and their role in squamous cell tumors.
Salgia R
Cancer Med; 2014 Jun; 3(3):681-92. PubMed ID: 24711160
[TBL] [Abstract][Full Text] [Related]
10. Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer.
Brooks AN; Kilgour E; Smith PD
Clin Cancer Res; 2012 Apr; 18(7):1855-62. PubMed ID: 22388515
[TBL] [Abstract][Full Text] [Related]
11. FGF/FGFR signaling in health and disease.
Xie Y; Su N; Yang J; Tan Q; Huang S; Jin M; Ni Z; Zhang B; Zhang D; Luo F; Chen H; Sun X; Feng JQ; Qi H; Chen L
Signal Transduct Target Ther; 2020 Sep; 5(1):181. PubMed ID: 32879300
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications.
Helsten T; Schwaederle M; Kurzrock R
Cancer Metastasis Rev; 2015 Sep; 34(3):479-96. PubMed ID: 26224133
[TBL] [Abstract][Full Text] [Related]
13. FGF-1 and FGF-7 induce distinct patterns of growth and differentiation in embryonic lung epithelium.
Cardoso WV; Itoh A; Nogawa H; Mason I; Brody JS
Dev Dyn; 1997 Mar; 208(3):398-405. PubMed ID: 9056643
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression.
Li Q; Alsaidan OA; Ma Y; Kim S; Liu J; Albers T; Liu K; Beharry Z; Zhao S; Wang F; Lebedyeva I; Cai H
J Biol Chem; 2018 Apr; 293(17):6434-6448. PubMed ID: 29540482
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for fibroblast growth factor receptor activation.
Mohammadi M; Olsen SK; Ibrahimi OA
Cytokine Growth Factor Rev; 2005 Apr; 16(2):107-37. PubMed ID: 15863029
[TBL] [Abstract][Full Text] [Related]
16. [FGF/FGFR signalling: Implication in oncogenesis and perspectives].
Flippot R; Kone M; Magné N; Vignot S
Bull Cancer; 2015 Jun; 102(6):516-26. PubMed ID: 25986739
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast Growth Factor Receptor Signaling in Skin Cancers.
Czyz M
Cells; 2019 Jun; 8(6):. PubMed ID: 31167513
[TBL] [Abstract][Full Text] [Related]
18. A novel type I fibroblast growth factor receptor activates mitogenic signaling in the absence of detectable tyrosine phosphorylation of FRS2.
Lopez ME; Korc M
J Biol Chem; 2000 May; 275(21):15933-9. PubMed ID: 10748122
[TBL] [Abstract][Full Text] [Related]
19. Increased FGF1-FGFRc expression in idiopathic pulmonary fibrosis.
MacKenzie B; Korfei M; Henneke I; Sibinska Z; Tian X; Hezel S; Dilai S; Wasnick R; Schneider B; Wilhelm J; El Agha E; Klepetko W; Seeger W; Schermuly R; Günther A; Bellusci S
Respir Res; 2015 Jul; 16(1):83. PubMed ID: 26138239
[TBL] [Abstract][Full Text] [Related]
20. Molecular characteristics of fibroblast growth factor-fibroblast growth factor receptor-heparin-like glycosaminoglycan complex.
Venkataraman G; Raman R; Sasisekharan V; Sasisekharan R
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3658-63. PubMed ID: 10097093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
